Neovacs S.A. (ALNEV) — Cash Flow Quality Index

Latest as of December 2020: -15.48x

Neovacs S.A. (ALNEV) has a Cash Flow Quality Index of -15.48x as of December 2020. Operating cash flow of €-4.58 Million is below net income of €295.70K, suggesting accrual-heavy earnings not yet converted to cash. Explore ALNEV cash generation efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

-15.48x

Operating CF / Net Income

Operating Cash Flow

€-4.58 Million

EUR

Net Income

€295.70K

EUR

Data as of

Dec 2020

Most recent filing

Annual Cash Flow Quality Index for Neovacs S.A. (None–None)

Year-by-year earnings quality comparison for Neovacs S.A.. For live market cap and the full company financial profile, see Neovacs S.A. stock valuation.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.